---
type: source
kind: report
title: "The Healthcare AI Adoption Index"
author: ["Sofia Guerra", "Steve Kraus"]
publisher: "Bessemer Venture Partners (Atlas), with Amazon Web Services and Bain & Company"
url: "https://www.bvp.com/atlas/the-healthcare-ai-adoption-index"
date_published: 2025-04-15
date_ingested: 2026-11-07
length: "one web report (~3,800 words + 16 chart images; text read in full, 3 charts transcribed; the SlideShare deck and appendix not accessible)"
raw: "../../raw/articles/2025-04-15-bessemer-healthcare-ai-adoption-index.md"
tags: [bessemer-venture-partners, aws, bain, health-care, payers, pharma, providers, genai-adoption, proof-of-concept, pilot-to-production, ambient-scribes, ai-dx-index, startups, co-development, vendor-survey, ai-maturity]
dynamic_capabilities:
  - digital-seizing/balancing-digital-portfolios
  - digital-sensing/digital-scouting
  - digital-transforming/navigating-innovation-ecosystems
relationships:
  - type: authored-by
    target: Bain-&-Company
    via: "survey partner; every chart is sourced 'Bain GenAI Survey (N=408)'"
  - type: authored-by
    target: Amazon-Web-Services
    via: "survey partner; Bessemer 'in partnership with AWS and Bain & Company, surveyed more than 400 leaders'"
  - type: supports
    target: 2026-08-01-bbc-ai-decoded-why-isnt-ai-working-for-your-company
    via: "pilot-to-production rate near 30%: Grant's vendor index (cross-industry, method not public) and the Bain survey of 408 health-care buyers (~30% of completed proofs of concept)"
    confidence: 0.65
  - type: supports
    target: 2026-04-09-dinakaran-yc-luminai-automating-americas-biggest-hospitals
    via: "selling AI startups into health systems: 55% of surveyed buyers would only consider startups with proven track records; Dinakaran describes trusted referrals as the way into hospital systems"
    confidence: 0.6
  - type: supports
    target: 2025-05-05-poon-jamia-health-system-ai-adoption
    via: "ambient documentation as the fastest-moving use case: 30% of surveyed providers with system-wide ambient-scribe deployments here; 100% activity and 14% full deployment of Ambient Notes among 43 US health systems in Poon et al."
    confidence: 0.65
  - type: supports
    target: 2026-04-09-qventus-cio-report-2026
    via: "pilots that do not reach production in US health care; note that Bessemer partner Steve Kraus sits on Qventus's board"
    confidence: 0.6
---

# The Healthcare AI Adoption Index — Bessemer Venture Partners, AWS and Bain & Company

> We partnered with AWS and Bain & Company to learn from 400+ healthcare buyers on what's driving AI experimentation, from proof-of-concept to production, and how this will impact startups and innovation partners.
>
> — the page's own summary

## TL;DR

A venture-capital report on a survey of **408 health-care executives** in three segments: payers (insurers), pharma and providers (health systems). The survey is Bain's; the framing is aimed at startup founders and buyers.

1. **About 30% of completed proofs of concept reach production.** *"Only ~30% of completed proofs of concept make it into production"* (chart 5). Payers 31%, pharma 24%, providers 35%; large providers 46%.
2. **Most use cases are still early.** *"Nearly half (45%) of the use cases"* across 59 jobs-to-be-done are *"still in the ideation or POC phase."* In chart 3, only 0–9% of use cases per category are in implementation or production (provider care 9%, revenue cycle 7%).
3. **Ambient scribes are the exception.** Among providers, *"30% have system-wide deployments, another 22% are in implementation, and another 40% are actively piloting"* ambient clinical documentation.
4. **Ambition and budget are not the constraint.** 95% say GenAI will be transformative; 60% see GenAI budgets growing faster than IT budgets; most say budget is not a barrier to scaling. The named barriers are security, in-house expertise, integration cost and AI-ready data.
5. **Startups supply under 15% of projects.** 64% of buyers are open to co-developing with startups, but 55% *"would only consider working with startups with proven track records."*

## Key data

| Measure | Figure | Where |
| --- | ---: | --- |
| Completed POCs that reach production | ~30% (payer 31%, pharma 24%, provider 35%) | chart 5 |
| … large providers | 46% | chart 5 |
| Use cases still in ideation or POC | 45% | "The state of AI adoption today" |
| Use cases in implementation/production, by category | 0–9% (care 9%, RCM 7%) | chart 3 |
| Providers with system-wide ambient-scribe deployment / implementing / piloting | 30% / 22% / 40% | same section |
| "Meaningful ROI within the first year" of GenAI implementation | 54% | same section |
| Have a clear AI strategy / an AI governance committee | about half / 57% | same section |
| GenAI budgets growing faster than IT budgets | 60% (payer 65%, pharma 57%, provider 56%) | "Experimentation but not yet production" |
| Barriers to scaling: security (payer / provider / pharma) | 61% / 50% / 52% | same section |
| … lack of in-house AI expertise | 41% / 48% / 52% | same section |
| … costly integrations | 51% / 43% / 49% | same section |
| … preparing AI-ready data | 39% / 41% / 47% | same section |
| Projects developed with or procured from startups | under 15% | "The development strategy" |
| Open to co-developing with startups | 64% | "How startups can win" |
| Expect positive ROI in under 12 months | 60% | same |

## Method and definitions

- **Sample.** *"More than 400 leaders across Payer, Pharma, and Provider segments"*; the chart footnotes give N = 408. The page does not give fieldwork dates, countries, job titles, how respondents were recruited or how many per segment.
- **Unit.** Organisations' projects and use cases, reported by executives. The 30% is a share of *completed* proofs of concept, not of all projects.
- **Stages.** Not started, ideation, proof of concept, pilot, implementation/production. The **AI Dx Index** scores 59 jobs-to-be-done on an Opportunity Score (pain and manual effort) and an Adoption Score (weighted stage average, *"Not Yet Started is 0-20% adoption and Implementation/Full Rollout is 80-100%"*).
- **Sponsors.** Bessemer Venture Partners (healthcare investor), Amazon Web Services (cloud provider, chosen *"for its unique position in the health AI ecosystem"*) and Bain & Company (consultancy, survey owner).

## Scope and reliability

- **Vendor- and investor-sponsored.** All three partners sell to or invest in the buyers surveyed. The report closes with advice for startups and points to the AWS Partner Network and AWS Marketplace.
- **Conflict worth naming.** Steve Kraus's bio lists a board seat at Qventus, a health-AI vendor whose CIO report is in this batch.
- **Thin method disclosure.** No fieldwork window, no country, no response rate. The full deck and appendix sit on SlideShare, which was not accessible.
- **Mixed segments.** Two thirds of the segments are not care providers; health-system figures are the provider subset only.
- **Self-reported ROI.** The 54% "meaningful ROI within the first year" has no definition of "meaningful".

## Dynamic-capabilities reading

- **`digital-seizing/balancing-digital-portfolios`**: the report is about the step from proof of concept to production, and how many experiments a portfolio carries to scale (~30%).
- **`digital-sensing/digital-scouting`**: a cross-segment scan of where health-care buyers are on the adoption curve, use case by use case.
- **`digital-transforming/navigating-innovation-ecosystems`**: it maps who builds health-care AI (internal teams, AI labs, cloud providers, incumbents, startups) and argues for co-development with startups.

## How it connects

- [[enterprise-ai-adoption]] — a pilot-to-production rate for one sector, with the breadth of experimentation set against few use cases in production.
- [[ai-maturity-measurement-comparison]] — a stage-based adoption measure per use case, from a vendor survey.
- [[2026-08-01-bbc-ai-decoded-why-isnt-ai-working-for-your-company|BBC AI Decoded]] — Peter Grant cites a vendor index that puts roughly 30% of pilots in production across industries; this survey gives a similar share for health-care proofs of concept.
- [[2026-04-09-dinakaran-yc-luminai-automating-americas-biggest-hospitals|Dinakaran (Luminai)]] — a startup selling automation into hospital systems through trusted referrals; this survey finds 55% of buyers only consider startups with a track record.
- In this batch: [[2025-05-05-poon-jamia-health-system-ai-adoption|Poon et al. (JAMIA 2025)]] measures ambient documentation and other use cases across 43 US health systems with a different stage scale. [[2026-04-09-qventus-cio-report-2026]] is a health-AI vendor's survey of US health-system CIOs on pilots and payoff.
- [[ai-in-health-care]]: the concept page that sets the health-care sources in this wiki side by side.

## What was actually ingested

The full article text as served on 7 November 2026, and transcriptions of three of the sixteen chart images (charts 1, 3 and 5). The SlideShare deck and appendix returned a bot challenge, and Bain's own page returned HTTP 403; neither was read. The recorded presentation was not transcribed.

## Linked entities and concepts

- [[Bain & Company]] — survey owner and partner.
- [[Amazon Web Services]] — partner.
- [[enterprise-ai-adoption]] — concept. [[ai-maturity-measurement-comparison]] — thread.

**Dangling** (single-source mention, deferred): Bessemer Venture Partners (publisher), Sofia Guerra (Bessemer partner, co-author), Steve Kraus (Bessemer partner, co-author; Qventus board member), Qventus (in Kraus's board list).
